WEST PHARMACEUTICAL SERVICES, INC. Capital Expenditures Incurred but Not yet Paid
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Capital Expenditures Incurred but Not yet Paid of $25.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$400.00K.
- WEST PHARMACEUTICAL SERVICES, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $26.10M, a 30.40% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$200.00K, a 107.41% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $2.70M, a 68.97% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $37.90M, a 28.49% decline from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $53.00M, a 0.56% decline from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $53.30M, a 60.54% increase from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $33.20M, a 19.22% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $25.70M 10-Q · filed 2026-07-23 | $25.50M derived: sum of 3 quarters · filed 2026-07-23 | $28.20M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $26.10M 10-Q · filed 2026-04-23 | $25.90M derived: sum of 2 quarters · filed 2026-04-23 | $28.60M derived: sum of 3 quarters · filed 2026-04-23 | $26.50M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.50M derived: sum of 2 quarters · filed 2026-02-17 | $400.00K derived: sum of 3 quarters · filed 2026-07-23 | $37.90M 10-K · filed 2026-02-17 |
| 2025-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $600.00K derived: sum of 2 quarters · filed 2026-07-23 | $38.10M 10-Q · filed 2025-10-23 | $40.80M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $35.40M 10-Q · filed 2026-07-23 | $38.10M derived: sum of 3 quarters · filed 2026-07-23 | $46.80M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $37.50M 10-Q · filed 2026-04-23 | $40.20M derived: sum of 2 quarters · filed 2026-04-23 | $48.90M derived: sum of 3 quarters · filed 2026-04-23 | $44.80M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $11.40M derived: sum of 2 quarters · filed 2026-02-17 | $7.30M derived: sum of 3 quarters · filed 2026-02-17 | $53.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $8.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $4.60M derived: sum of 2 quarters · filed 2025-10-23 | $50.30M 10-Q · filed 2025-10-23 | |
| 2024-06-30 | -$4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $41.60M 10-Q · filed 2025-07-24 | ||
| 2024-03-31 | $45.70M 10-Q · filed 2025-04-24 | |||
| 2023-12-31 | $53.30M 10-K · filed 2026-02-17 | |||
| 2022-12-31 | $33.20M 10-K · filed 2025-02-18 | |||
| 2021-12-31 | $41.10M 10-K · filed 2024-02-20 | |||
| 2020-12-31 | $31.30M 10-K · filed 2023-02-21 | |||
| 2019-12-31 | $17.00M 10-K · filed 2022-02-22 | |||
| 2018-12-31 | $15.00M 10-K · filed 2021-02-23 | |||
| 2017-12-31 | $20.10M 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $22.70M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $25.00M 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $21.00M 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $17.10M 10-K · filed 2016-02-26 | |||
| 2012-12-31 | $54.30M 10-K · filed 2015-02-25 | |||
| 2011-12-31 | $33.80M 10-K · filed 2014-02-27 | |||
| 2010-12-31 | $7.10M 10-K · filed 2013-02-27 | |||
| 2009-12-31 | $9.90M 10-K/A · filed 2012-03-01 | |||
| 2008-12-31 | $9.80M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |